Pfizer's new experimental vaccine for RSV is over 85% effective in older adults, according to a Thursday announcement from the company. A trial vaccine for the respiratory syncytial virus (RSV) was 86 ...

Three doses of Pfizer’s vaccine and a two-doses of Moderna’s shot are safe and effective in preventing illness from Covid-19 in young children, according to assessments provided by the Food and Drug ...

Pfizer and BioNTech are seeking emergency use authorization of its COVID vaccine for kids under 5 after preliminary data revealed a third dose elicited a “strong immune response” A third dose of the ...

Pfizer Inc and BioNTech's vaccine was 73.2% effective in preventing COVID-19 among children aged 6 months through 4 years, new data from the companies showed on Tuesday, two months after the U.S.

NEW YORK -- Three child-size doses of the Pfizer/BioNTech Covid-19 vaccine appeared to be safe and showed a strong immune response in children ages 6 months to 5 years, the companies said Monday. The ...

WASHINGTON — Federal health officials said Sunday that kid-sized doses of Pfizer’s Covid-19 vaccines appear to be safe and effective for kids under 5, a key step toward a long-awaited decision to ...

Pfizer’s vaccine to protect newborns from respiratory syncytial virus, or RSV, by vaccinating their moms late in pregnancy cuts the risk that infants will need to see a doctor or be admitted to the ...